Parrella Health Law

Embracing the New Era of Healthcare Compliance: Navigating the OIG’s 2023...

The Office of Inspector General (OIG) of the U.S. Department of Health and Human Services has taken a significant step forward in promoting compliance best practices with the release of its updated General Compliance Program Guidance (GCPG) on...

Read More ›
Parrella Health Law

Navigating the Complexities of Telehealth and DME Fraud: Lessons from a...

By: Christopher A. Parrella, Esq., CPC, CHC, CPCO Parrella Health Law, Boston, Mass. In the rapidly evolving landscape of healthcare, the integration of telemedicine has offered numerous benefits, enhancing patient access to care and enabling more...

Read More ›
Parrella Health Law

An Analysis of OIG Advisory Opinion No. 23-07 on Physician Bonuses

The Office of Inspector General (OIG) recently issued Advisory Opinion No. 23-07 addressing a key concern in healthcare compliance – the payment of bonuses to employed physicians based on net profits from certain procedures. This article aims to...

Read More ›
Parrella Health Law

Telemedicine and Its Dark Side: The $7.8 Million Scandal Explained

In the rapidly evolving world of telemedicine, where technology offers the promise of broader healthcare access, not everything glitters. A recent incident reveals a shadowy corner of this innovative field, drawing attention to the system's...

Read More ›
Parrella Health Law

Federal Government Extends Telehealth Flexibilities: Implications for DEA Regulation of Controlled...

The federal government's decision to prolong the COVID-era telehealth flexibilities until December 2024 signifies a substantial shift in the landscape for healthcare professionals and telehealth providers. It's evident that the Drug Enforcement...

Read More ›
Parrella Health Law

US Takes Historic Steps Against Fentanyl Suppliers: A Comprehensive Approach to...

The opioid crisis has been an ever-present and ever-growing concern in the United States, especially with the rise of synthetic opioids like fentanyl. In a bold and historic move, the Biden administration has taken decisive action against the key...

Read More ›